Targeting CXADR Suppresses Tumorigenesis And Enhances Chemotherapy Efficacy In Ewing Sarcoma
Researchers recently discovered that a specific viral receptor gene called CXADR is highly active in patients with the worst Ewing
Read MoreResearchers recently discovered that a specific viral receptor gene called CXADR is highly active in patients with the worst Ewing
Read MoreA recent study presented at the 2026 ASCO Annual Meeting reveals that an oral drug called abemaciclib (brand name Verzenio)
Read MoreAdolescent and young adult (AYA) patients with sarcoma often fall into a medical “gray area” because they are too old
Read MoreResearchers have discovered that a specific protein called UBA1 is found in much higher amounts in Ewing Sarcoma cells compared
Read MoreThe METTSEO trial is a new Phase 1 clinical study sponsored by the Moffitt Cancer Center for patients newly diagnosed
Read MorePatients fighting Ewing sarcoma often respond well to their first round of treatment. However, if the cancer returns (relapses) or
Read MoreBecause childhood cancers are rare, finding funding and developing new treatments for them is incredibly difficult; in fact, the standard
Read MoreChildhood cancer survivors face a higher risk of developing serious long-term health issues such as heart disease and other cancers
Read MoreResearchers at the University of Birmingham discovered a new genetic indicator, called a “biomarker,” that can predict which children with
Read MoreDoctors are using a advanced tool called “genomic tumor profiling” to better understand and treat rare muscle and bone cancers
Read More